Does HIV-1 subtype D have a higher risk of vertical transmission than other HIV subtypes?

Journal of Infectious Diseases

Volumn 199, Issue 10, 2009, Pages 1553-1554

  Krivine, Anne ^a,b   Launay, Odile ^a,c,e   Firtion, Ghislaine ^a,c   Finkielsztejn, Laurent ^a,c   Jullien, Vincent ^a,d,e   Rozenberg, Flore ^a,b,e   Pannier, Emmanuelle ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Laboratoire de Virologie   (France)

^c Maternité Cochin Port Royal   (France)

^d Groupe Hospitalier Cochin Saint Vincent de Paul ^*  (United States)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ANAMNESIS; ANTIVIRAL THERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; INFECTION RISK; LETTER; LYMPHOCYTE COUNT; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMIDINONES; RISK FACTORS; SURVIVAL RATE; VIRAL LOAD; YOUNG ADULT;

EID: 65549156188     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598481     Document Type: Letter

References (12)

1. Church JD, Huang W, Mwatha A, et al. HIV-1 tropism and survival in vertically infected Ugandan infants. J Infect Dis 2008;197:1382- 8.
2. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in theANRSFrench Perinatal Cohort. AIDS 2008; 22:289-99.
3. NCBI genotyping tool. Available at: http://www.ncbi.nlm.nih.gov/projects/ genotyping/formpage.cgi. Accessed 26 March 2009.
4. Geno2pheno. Available at: http://www.geno2pheno.org/index.php. Accessed 26 March 2009.
5. WebPSSM. Available at: http://indra.mullins.microbiol.washington.edu/ pssm/. Accessed 26 March 2009.
6. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006; 20:W13-23.
7. Kiwanuka N, Laeyendecker O, Robb M, et al. Effect ofhumanimmunodeficiencyvirus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008; 197:707-13.
8. Baeten JM, Chohan B, Lavreys L, et al. HIV-1 subtypeDinfection is associated with faster disease progression than subtypeAin spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195: 1177-80.
9. Huang W, Eshleman SH, Toma J, et al. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 2007; 81:7885-93.
10. Eshleman SH, Guay LA, Mwatha A, et al. Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012. J Acquir Immune Defic Syndr 2005; 39:593-7.
11. Yang C, Li M, Newman RD, et al. Genetic diversity of HIV-1 in western Kenya: subtypespecific differences in mother-to-child transmission. AIDS 2003; 17:1667-74.
12. Yeni P. Prise en charge médicale des personnes infectées par le VIH: recommandations du groupe d'experts. Paris, France: Flammarion Médecine Sciences, 2008:144-61.